A team of researchers affiliated with multiple institutions in and around the Boston area in the U.S. and one in Finland has identified hundreds of possible causal variants associated with blood cell traits, and tied them ...
Under normal, healthy circulatory conditions, the von Willebrand Factor (vWF) keeps to itself. The large and mysterious glycoprotein moves through the blood, balled up tightly, its reaction sites unexposed. But when significant ...
Apr 28, 2021
0
183
Platelets are involved in blood coagulation and the development of thrombosis. Researchers from Utrecht University, UMC Utrecht, and Erasmus MC have now discovered that they also play a role in the immune system: They appear ...
Jul 1, 2020
0
6
An experimental blood thinning drug made by the pharmaceutical giant Merck may reduce the risk of dying from a heart attack but also boosts the danger of internal bleeding, researchers said Saturday.
Mar 24, 2012
0
0
An unexpected finding in pre-clinical platelet studies by Baker Institute researchers could provide a novel approach to targeting and destroying difficult-to-treat cancer cells, providing new therapeutic options for a range ...
Feb 8, 2019
0
8
Biomedical researchers at Case Western Reserve University report that their latest innovation in developing synthetic platelets could help save lives by rapidly stabilizing clots to reduce blood loss from traumatic injuries.
Jan 26, 2022
0
33
January is National Blood Donor Month, which makes this a good time to become a blood donor.
Jan 20, 2022
0
0
An antibody packaged with a potent chemotherapy drug to selectively destroy acute lymphoblastic leukemia (ALL) cells eradicated or greatly reduced the disease for 61 percent of 46 patients in a phase II study. It will be ...
May 23, 2011
0
0
As blood stem cells age, changes in the epigenome—the system that regulates which genes are switched on and which are switched off throughout the body—alter these cells in ways that lead to reduced immune response, increased ...
Feb 15, 2013
0
0
The first-in-class novel human immunoglobulin G1 Fc fragment, efgartigimod, is efficacious and safe for patients with chronic or persistent primary immune thrombocytopenia, according to a study published online Sept. 28 in ...
Oct 6, 2023
0
4
